Skip to content
healthcare.dev

14% Azelaic Acid

NDC 87815-003, Azelaic Acid, cream, from Guangzhou Ariel Medical Technology Co., Ltd..

Product NDC
87815-003
Status
Listed
Labeler
Guangzhou Ariel Medical Technology Co., Ltd.
Dosage form
CREAM
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M006
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87815-003 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AZELAIC ACID14 g/100g

Pharmacologic classes

Decreased Protein Synthesis [PE]; Decreased Sebaceous Gland Activity [PE]

Package NDCNDC-11Package
87815-003-018781500030130 g in 1 TUBE (87815-003-01)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 87815-003 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87815-003 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87815-003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.